Cart
sales@molnova.com
N-trans-Sinapoyltyramine
CAS No. 200125-11-7
N-trans-Sinapoyltyramine( —— )
Catalog No. M23901 CAS No. 200125-11-7
N-trans-Sinapoyltyramine exhibited strong and selective cytotoxicity on the HeLa human cancer cell line with IC50 values of 9.77 ± 1.25 Μm.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 599 | In Stock |
|
| 5MG | 589 | In Stock |
|
| 10MG | 838 | In Stock |
|
| 25MG | 1264 | In Stock |
|
| 50MG | 1655 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-trans-Sinapoyltyramine
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-trans-Sinapoyltyramine exhibited strong and selective cytotoxicity on the HeLa human cancer cell line with IC50 values of 9.77 ± 1.25 Μm.
-
DescriptionN-trans-Sinapoyltyramine exhibited strong and selective cytotoxicity on the HeLa human cancer cell line with IC50 values of 9.77 ± 1.25 Μm.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number200125-11-7
-
Formula Weight343.37
-
Molecular FormulaC19H21NO5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cc(/C=C/C(NCCc(cc2)ccc2O)=O)cc(OC)c1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Truong LH, et al. Cytotoxic constituents from Isotrema tadungense. J Asian Nat Prod Res. 2021 May;23(5):491-497.
molnova catalog
related products
-
KRN2 bromide
KRN2 bromide is a selective NFAT5 inhibitor with an IC50 of 100 nM.?
-
2-Hydroxycaprylic ac...
2-Hydroxycaprylic acid belongs to the class of organic compounds known as medium-chain fatty acids.
-
BMS-986235
BMS-986235 is a selective and orally active agonist of formyl peptide receptor 2 (FPR2) with EC50s of 0.41 nM and 3.4 nM for hFPR2 and mFPR2, respectively.
